oral glp 1 pfizer Woke up to news that just halted their GLP-1 candidate after a liver injury was reported in Phase 1. Two thoughts immediately came to mind: 1. This is exactly why Oral GLP-1 Wegovy chases approval

tariffs have disrupted the global solvent supply chain, pushing prices higherparticularly on specialty chemicals with no domestic suppliers

Re-using syringes, not swabbing the vial tops, or working in a dirty environment are all invitations for contamination

Role of Glycated Proteins in the Diagnosis and Management of Diabetes: Research Gaps and Future Directions

Tirzepatide: dual-pathway incretin research compound with broad vial-size coverage

Also Read: Weight Loss and Obesity Management Market Size, Share, & Trend Analysis Report for 2025-2032 High Treatment Costs and Non-Pharmacological Approaches Limiting Growth The global anti-obesity drug market outlook remains positive, owing to rising incidence of obesity and other lifestyle diseases